RONALD G. FRAGGE, M.D.; FREDRIC B. KOPEL, M.D.; ARNOLD IGLAUER, M.D., F.A.C.P.
Considerable confusion has arisen in the interpretation of serum glutamic oxalacetic transaminase (SGO-T) levels as the number of clinical conditions to which this determination has been applied has increased. This refers in particular to congestive heart failure. Numerous series have been reported in which the levels of SGO-T have varied widely. Some observers have reported that acute congestive heart failure with liver engorgement may be associated with significant SGO-T elevation. Another author has stated that right heart failure does not ordinarily affect significantly the level of SGO-T activity.
Records of patients with congestive heart failure were surveyed from
Learn more about subscription options.
Register Now for a free account.
FRAGGE RG, KOPEL FB, IGLAUER A. SERUM GLUTAMIC OXALACETIC TRANSAMINASE (SGO-T) IN CONGESTIVE HEART FAILURE: CLINICAL STUDY AND REVIEW OF THE LITERATURE(SERUM GLUTAMIC OXALACETIC TRANSAMINASE (SGO-T) IN CONGESTIVE HEART FAILURE: CLINICAL STUDY AND REVIEW OF THE LITERATURE*). Ann Intern Med. 1960;52:1042–1050. doi: 10.7326/0003-4819-52-5-1042
Download citation file:
Published: Ann Intern Med. 1960;52(5):1042-1050.
Cardiology, Heart Failure.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only